PackHealth: Asthma Engagement Tool
Assessing the Impact of a Patient-Clinician Engagement Tool on Patient Reported Outcomes and Engagement in Asthma
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Patient engagement is a critical part of improving patient care and outcomes. Current patient engagement strategies only focus on the patient-physician interaction and have been shown to be ineffective.
The need for a comprehensive approach to patient engagement is no different among patients with asthma as it is in any other chronic condition. Patients with asthma must make complicated health decisions daily that impact their social and occupational activities, quality of life, and treatment adherence. Obtaining, communicating, processing, and understanding non- biased health information are crucial in making appropriate and informed treatment decisions.
Pack Health LLC and Duke will develop a patient engagement toolkit known as "Packs" to help empower and engage patients. These disease-specific, evidence-based kits are scientifically designed to improve patient involvement in their own care. Each Pack draws on the science of change management and patient activation and contains three categories of materials
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
North Carolina
-
Durham, North Carolina, Forenede Stater, 27705
- Duke Asthma Allergy and Airway Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients with a physician diagnosis of asthma for at least the previous 12 months.
- Asthma that is not well controlled by NAEPP guidelines.
- Ability and willingness to provide informed consent
Exclusion Criteria:
- Significant alcohol consumption of more than three alcoholic drinks per day or active substance abuse.
- Chronic disease (other than asthma) that in the opinion of the investigator would prevent participation in the trial or put the participant at risk by participation e.g. chronic diseases of the lung (other than asthma), heart, liver, kidney, endocrine or nervous system or immunodeficiency that are not well addressed or controlled.
- A diagnosis of cancer with ongoing treatment.
- Any terminal illness or conditions that results in a life expectancy less than one year.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: Asthma Patients
Patient engagement toolkit
|
Pack Health LLC and Duke will develop a patient engagement toolkit known as "Packs" to help empower and engage patients.
These disease-specific, evidence-based kits are scientifically designed to improve patient involvement in their own care
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Rate of Asthma Exacerbations
Tidsramme: 12 weeks prior to baseline
|
The average number of asthma events requiring treatment with oral corticosteroids, emergency room visits or hospitalizations that occurred 12 weeks before baseline.
|
12 weeks prior to baseline
|
|
Rate of Asthma Exacerbations
Tidsramme: baseline to week 13
|
The average number of asthma events requiring treatment with oral corticosteroids, emergency room visits or hospitalizations from baseline to week 13
|
baseline to week 13
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Asthma Control
Tidsramme: baseline, 13 weeks
|
Measured by the Asthma Control Test (ACT), patient self-administered tool for identifying those with poorly controlled asthma.
The ACT assesses the frequency of dyspnea and general asthma symptoms, use of rescue medications, the effect of asthma on daily functioning, and overall self-assessment of asthma control.
5 items with 4-week recall.
The score range is 5-25 with >19 representing good control and <18 representing poor control.
|
baseline, 13 weeks
|
|
Change in Asthma Symptoms
Tidsramme: baseline, 13 weeks
|
Measured by asthma symptom utility index (ASUI). The Asthma Symptom utility Index (ASUI) is a brief, interviewer-administered, patient preference-based scale assessing frequency and severity of asthma-related symptoms and treatment side effects. Number of items 11 items with 2 week recall. Scores range from 0 (worst possible symptoms) to 1 (no symptoms) Minimal Clinically Important Difference (MCID) > 0.09 |
baseline, 13 weeks
|
|
Change in Pulmonary Function Tests
Tidsramme: baseline, 13 weeks
|
Measured by spirometry.
We measured forced expiratory volume in one second (FEV1) and forced vital capacity both in liters.
FEV1 is a measure of airflow obstruction.
The change in lung function is the change in these measurements compared to baseline.
|
baseline, 13 weeks
|
|
Number of Emergency Department and Hospitalization Visits
Tidsramme: Prior Year
|
Number of emergency department and hospitalizations visits will be recorded that occurred within the prior year.
|
Prior Year
|
|
Number of Emergency Department and Hospitalization Visits
Tidsramme: 13 weeks
|
Number of emergency department and hospitalization visits will be recorded
|
13 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Njira Lugogo, MD, Duke University
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Pro00057939
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Patient engagement toolkit
-
University of California, BerkeleyDartmouth College; Advocate Health Care; HealthCare Partners Institute for...AfsluttetKardiovaskulær sygdom | DiabetesForenede Stater
-
Hacettepe UniversityThe Scientific and Technological Research Council of TurkeyAfsluttetType 2 diabetes | Patientengagement | Overholdelse, tålmodig | SelveffektivitetKalkun
-
University of MichiganAfsluttetKvinder med BRCA 1 eller BRCA 2 mutation | Ikke-testede kvindelige familiemedlemmerForenede Stater
-
Soberlink Healthcare LLCMAP Health Management LLCAfsluttet
-
University of TorontoUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; McMaster... og andre samarbejdspartnereAfsluttet
-
Yale UniversityNational Institutes of Health (NIH); National Institute on Aging (NIA); Trinity...AfsluttetDiabetes mellitus | DiabetesForenede Stater
-
University of ChicagoNational Institute on Minority Health and Health Disparities (NIMHD); Rush... og andre samarbejdspartnereAktiv, ikke rekrutterendeSkrøbelighedForenede Stater
-
University of MichiganThe Craig H. Neilsen FoundationAfsluttetAccept- og forpligtelsesterapi for kronisk smerte ved SCI: Udvikling og test af et e-sundhedsprogramRygmarvsskaderForenede Stater
-
Duke UniversityDuke Clinical Research InstituteAfsluttetHjertefejlForenede Stater
-
University of PennsylvaniaAfsluttet